SLC7A1 and endothelial dysfunction: Arginine is also the biological precursor for nitric oxide, and it is possible that altered CAT-1 expression could reduce bioavailability of nitric oxide, thereby contributing indirectly to endothelial dysfunction and altered BBB properties [95].